Jennifer Southall

The NIH and NCI awarded a $4 million grant to Paula Aristizabal, MD, MAS, to expand a pilot program aimed at increasing diverse participation in pediatric cancer clinical trials.

Patients treated by female surgeons experienced lower heath care costs compared with those treated by male surgeons, according to study results. The findings, published in JAMA Surgery, add to the growing data that back the creation of inclusive policies and environments supportive of female surgeons to improve recruitment and retention of a more diverse and representative workforce, researchers

Pembrolizumab plus olaparib did not improve outcomes among patients with locally recurrent inoperable or metastatic triple-negative breast cancer, according to study results presented at San Antonio Breast Cancer Symposium.

A novel digital health coaching program did not improve patient-reported outcomes among individuals with active breast cancer, according to study results presented at San Antonio Breast Cancer Symposium.Additional research is needed to identify best practices for digital health care interventions, researchers concluded.

Patients undergoing treatment for active breast cancer reported experiencing significant financial burden from cancer care, according to survey results. The findings — presented at San Antonio Breast Cancer Symposium — indicate a need for patient-centered solutions to lessen financial burdens and optimize patient outcomes. These solutions could include direct assistance and patient

The Miami Dolphins and AutoNation awarded a $1 million grant to Neha Goel, MD, MPH, FACS, to examine the critical health disparities that drive mortality among patients with breast cancer. The funding will support a 4-year Breast Cancer Research Foundation project and continue to support the Miami Breast Cancer Disparities Study.

Revumenib proved safe and effective among pediatric and adult patients with relapsed or refractory KMT2Ar acute myeloid leukemia and acute lymphoid leukemia, according to study results presented at ASH Annual Meeting and Exhibition.

Reduced-intensity haploidentical-bone marrow transplant showed durable donor engraftment at 2-years follow-up with low mortality among adults with severe sickle cell disease, according to study results.

Ibrutinib plus venetoclax demonstrated superior PFS and a higher complete response rate compared with ibrutinib plus placebo in patients with relapsed or refractory mantle cell lymphoma, according to study results.

First-generation medical students reported experiencing increased adversity with inadequate institutional support during undergraduate medical training, according to study results published in JAMA Network Open. Researchers recommend targeted and flexible interventions so that all students — regardless of background — have the same opportunities to achieve robust professional